DigestRedComo funciona
Red
/
Empresas
Ka
No verificado

Kairos Pharma, Ltd

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaOncologíaSalud

24 Comunicados de prensa

Ver todos los comunicados de prensa
20/01/2026
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Kairos Pharma to Present at 3rd Annual DealFlow Discovery Conference
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
17/12/2025
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
20/10/2025
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
07/10/2025
Salud
Ciencia
Farmacéutica
Oncología
Eventos
Kairos Pharma to Present Positive Safety and Efficacy Data from Phase 2 Prostate Cancer Trial at ESMO 2025
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
18/09/2025
Farmacéutica
Salud
Oncología
Medicina - Varios
Web y redes sociales
Industria
Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of ENV105 in Advanced Prostate Cancer with Median Progression Free Survival of Over One Year
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
11/09/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Finanzas
Web y redes sociales
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
03/09/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Ferias y Congresos
Industria
Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
02/09/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Web y redes sociales
Eventos
Finanzas
Kairos Pharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
16/07/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Kairos Pharma Announces Participation and Presentation in the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
15/07/2025
Ciencia
Medicina - Varios
Sanidad
Biotecnología
Farmacéutica
Salud
Oncología
Industria
Kairos Pharma Announces Positive Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate Cancer
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0